Investigation Launched into 89bio, Inc. Regarding Recent Acquisition Deal Class Action Attorney Juan Monteverde is investigating 89bio, Inc. following its sale to Roche Holdings, questioning the fairness of the offer made to shareholders.

Investigation Launched into 89bio, Inc. Regarding Recent Acquisition Deal #USA #New_York #Class_Action #Roche_Holdings #89bio

Monteverde & Associates Investigates Poseida Therapeutics Merger Proposal with Roche Holdings Monteverde & Associates PC investigates the proposed merger between Poseida Therapeutics and Roche Holdings. Shareholders may need to take action.

Monteverde & Associates Investigates Poseida Therapeutics Merger Proposal with Roche Holdings #United_States #New_York #Monteverde_Associates #Poseida_Therapeutics #Roche_Holdings

Poseida Therapeutics Announces Acquisition by Roche Holdings to Enhance CAR-T Therapy Pipeline Poseida Therapeutics has entered into a merger agreement to be acquired by Roche Holdings for up to $13.00 per share, enhancing CAR-T therapy R&D.

Poseida Therapeutics Announces Acquisition by Roche Holdings to Enhance CAR-T Therapy Pipeline #United_States #San_Diego #Poseida_Therapeutics #Roche_Holdings #CAR-T_therapy